PreCAAP Company: Tieös Pharmaceuticals Inc. Chosen as Semi-Finalist in 2017 BioInnovation Challenge (BIC)

Scott Moffitt, Managing Director of BioNova & the host of BIC, announced the semi-finalists which included Tieos Pharmaceuticals. All semi-finalists will receive professional pitch training between now and the semi-final run off, which will be held in Halifax on October 17.

The program is part of a regional collaboration between BioNova, BioNB and PEI BioAlliance, its sister organizations in NB and PEI. The program allows up and coming life sciences companies to compete in the challenge and kick start their success.

For the full press release click here